HRP20120225T1 - Novi heterociklični spojevi kao mglu5 antagonisti - Google Patents
Novi heterociklični spojevi kao mglu5 antagonisti Download PDFInfo
- Publication number
- HRP20120225T1 HRP20120225T1 HR20120225T HRP20120225T HRP20120225T1 HR P20120225 T1 HRP20120225 T1 HR P20120225T1 HR 20120225 T HR20120225 T HR 20120225T HR P20120225 T HRP20120225 T HR P20120225T HR P20120225 T1 HRP20120225 T1 HR P20120225T1
- Authority
- HR
- Croatia
- Prior art keywords
- pyridyl
- piperidine
- prop
- ynylidene
- methyl
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 16
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 2
- -1 C1-C6alkyl Chemical group 0.000 claims 41
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 9
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 239000001301 oxygen Chemical group 0.000 claims 6
- 239000011593 sulfur Chemical group 0.000 claims 6
- 229910052717 sulfur Chemical group 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 5
- 125000004043 oxo group Chemical group O=* 0.000 claims 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 229910052731 fluorine Chemical group 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 3
- 150000001204 N-oxides Chemical class 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- OMYXXSPBDPYMFE-UHFFFAOYSA-N (2-methoxypyridin-3-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound COC1=NC=CC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 OMYXXSPBDPYMFE-UHFFFAOYSA-N 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 2
- MIJHAQQBDWIIQY-UHFFFAOYSA-N 3-nitro-2-[4-[3-(6-propan-2-yloxypyridin-3-yl)prop-2-ynylidene]piperidin-1-yl]pyridine Chemical compound C1=NC(OC(C)C)=CC=C1C#CC=C1CCN(C=2C(=CC=CN=2)[N+]([O-])=O)CC1 MIJHAQQBDWIIQY-UHFFFAOYSA-N 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- 125000005466 alkylenyl group Chemical group 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000005493 quinolyl group Chemical group 0.000 claims 2
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- ZPEVOJQFBXKZRB-UHFFFAOYSA-N (1-methylbenzotriazol-5-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C3N=NN(C)C3=CC=2)=N1 ZPEVOJQFBXKZRB-UHFFFAOYSA-N 0.000 claims 1
- RNDLSDSZAWFVSX-UHFFFAOYSA-N (2,5-dichlorothiophen-3-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C2=C(SC(Cl)=C2)Cl)=N1 RNDLSDSZAWFVSX-UHFFFAOYSA-N 0.000 claims 1
- DXCWJRFKJZNEFA-UHFFFAOYSA-N (2,5-dimethylfuran-3-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound O1C(C)=CC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1C DXCWJRFKJZNEFA-UHFFFAOYSA-N 0.000 claims 1
- DQMBFUATWQSSKR-UHFFFAOYSA-N (2,6-dimethoxypyridin-3-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound COC1=NC(OC)=CC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 DQMBFUATWQSSKR-UHFFFAOYSA-N 0.000 claims 1
- OYBWNZHHFZBUQW-UHFFFAOYSA-N (2-chloro-6-methoxypyridin-4-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound ClC1=NC(OC)=CC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1 OYBWNZHHFZBUQW-UHFFFAOYSA-N 0.000 claims 1
- ZSGOSJRTWAOZNV-UHFFFAOYSA-N (2-chloro-6-methylpyridin-4-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(Cl)N=C(C)C=2)=N1 ZSGOSJRTWAOZNV-UHFFFAOYSA-N 0.000 claims 1
- CPCBQVROYOGMHU-UHFFFAOYSA-N (2-methoxyphenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound COC1=CC=CC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 CPCBQVROYOGMHU-UHFFFAOYSA-N 0.000 claims 1
- UQGHKOIGZYELRM-UHFFFAOYSA-N (3-bromophenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(Br)C=CC=2)=N1 UQGHKOIGZYELRM-UHFFFAOYSA-N 0.000 claims 1
- XOGNAHSODCBNIF-UHFFFAOYSA-N (3-chloro-4-methylthiophen-2-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CSC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1Cl XOGNAHSODCBNIF-UHFFFAOYSA-N 0.000 claims 1
- PGBLXONVLMXXEL-UHFFFAOYSA-N (3-chlorophenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(Cl)C=CC=2)=N1 PGBLXONVLMXXEL-UHFFFAOYSA-N 0.000 claims 1
- MDPMQATZMWHZOW-UHFFFAOYSA-N (3-chlorothiophen-2-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C2=C(C=CS2)Cl)=N1 MDPMQATZMWHZOW-UHFFFAOYSA-N 0.000 claims 1
- JWEDDRDNMGBIDH-UHFFFAOYSA-N (3-ethoxythiophen-2-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound C1=CSC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1OCC JWEDDRDNMGBIDH-UHFFFAOYSA-N 0.000 claims 1
- MDIBBZYMQUDVAP-UHFFFAOYSA-N (3-fluorophenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(F)C=CC=2)=N1 MDIBBZYMQUDVAP-UHFFFAOYSA-N 0.000 claims 1
- MHHPFSKBUYYGND-UHFFFAOYSA-N (3-iodophenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(I)C=CC=2)=N1 MHHPFSKBUYYGND-UHFFFAOYSA-N 0.000 claims 1
- RKYZXRFHJBMXQG-UHFFFAOYSA-N (3-methoxyphenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound COC1=CC=CC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1 RKYZXRFHJBMXQG-UHFFFAOYSA-N 0.000 claims 1
- WDPLWWIVTYHGQW-UHFFFAOYSA-N (3-methyl-2-nitrophenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C(=C(C)C=CC=2)[N+]([O-])=O)=N1 WDPLWWIVTYHGQW-UHFFFAOYSA-N 0.000 claims 1
- LZRUXBNIOGLOTR-UHFFFAOYSA-N (3-methylfuran-2-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound C1=COC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1C LZRUXBNIOGLOTR-UHFFFAOYSA-N 0.000 claims 1
- GNTARZNMPMOBPT-UHFFFAOYSA-N (3-methylphenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1 GNTARZNMPMOBPT-UHFFFAOYSA-N 0.000 claims 1
- YZZMULHNICLQPX-UHFFFAOYSA-N (4-methoxyphenyl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound C1=CC(OC)=CC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 YZZMULHNICLQPX-UHFFFAOYSA-N 0.000 claims 1
- UXOCKEHHODLDQN-UHFFFAOYSA-N (5-bromofuran-2-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2OC(Br)=CC=2)=N1 UXOCKEHHODLDQN-UHFFFAOYSA-N 0.000 claims 1
- ZJHPKKQZJXHVJK-UHFFFAOYSA-N (5-chloro-4-methoxythiophen-3-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound COC1=C(Cl)SC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 ZJHPKKQZJXHVJK-UHFFFAOYSA-N 0.000 claims 1
- YADWZUXTFVSUHB-UHFFFAOYSA-N (5-chlorothiophen-2-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2SC(Cl)=CC=2)=N1 YADWZUXTFVSUHB-UHFFFAOYSA-N 0.000 claims 1
- DIKAHMSJXQAWGS-UHFFFAOYSA-N (5-methoxy-1h-indol-3-yl)-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound C12=CC(OC)=CC=C2NC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 DIKAHMSJXQAWGS-UHFFFAOYSA-N 0.000 claims 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 1
- AXTNJZANAMZJIO-UHFFFAOYSA-N 1-(3-fluoro-4-methylphenyl)-4-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidine-1-carbonyl]pyrrolidin-2-one Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C2CC(=O)N(C2)C=2C=C(F)C(C)=CC=2)=N1 AXTNJZANAMZJIO-UHFFFAOYSA-N 0.000 claims 1
- NMJVUEOQYJUQLZ-UHFFFAOYSA-N 1-(3-methyl-5-nitroimidazol-4-yl)-4-(4-phenylbut-3-yn-2-ylidene)piperidine Chemical compound C1CN(C=2N(C=NC=2[N+]([O-])=O)C)CCC1=C(C)C#CC1=CC=CC=C1 NMJVUEOQYJUQLZ-UHFFFAOYSA-N 0.000 claims 1
- AIKLEXWZQOVZKE-UHFFFAOYSA-N 1-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyrrolidin-2-one Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CN1C(=O)CCC1 AIKLEXWZQOVZKE-UHFFFAOYSA-N 0.000 claims 1
- ICAPTLMFNWCLJV-UHFFFAOYSA-N 1-[3-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CN=2)[N+]([O-])=O)=C1 ICAPTLMFNWCLJV-UHFFFAOYSA-N 0.000 claims 1
- IUWWNWGTFOYBMU-UHFFFAOYSA-N 1-[3-[3-[1-(6-methyl-3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=C(C)N=2)[N+]([O-])=O)=C1 IUWWNWGTFOYBMU-UHFFFAOYSA-N 0.000 claims 1
- ZJRGHFAQHZFQBU-UHFFFAOYSA-N 1-[3-[3-[1-(6-methyl-3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]phenyl]propan-2-one Chemical compound CC(=O)CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=C(C)N=2)[N+]([O-])=O)=C1 ZJRGHFAQHZFQBU-UHFFFAOYSA-N 0.000 claims 1
- CTEWKELQIGCQGY-UHFFFAOYSA-N 1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-2-(2-nitrophenoxy)ethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)COC=2C(=CC=CC=2)[N+]([O-])=O)=N1 CTEWKELQIGCQGY-UHFFFAOYSA-N 0.000 claims 1
- QDVDEVISNSQSMF-UHFFFAOYSA-N 1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-4-phenylbutan-1-one Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)CCCC=2C=CC=CC=2)=N1 QDVDEVISNSQSMF-UHFFFAOYSA-N 0.000 claims 1
- HEWBJUZWTAYGRE-UHFFFAOYSA-N 1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CCC)CCC1=CC#CC1=CC=CC(C)=N1 HEWBJUZWTAYGRE-UHFFFAOYSA-N 0.000 claims 1
- SFMRYRUMXONSQK-UHFFFAOYSA-N 1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]heptan-1-one Chemical compound C1CN(C(=O)CCCCCC)CCC1=CC#CC1=CC=CC(C)=N1 SFMRYRUMXONSQK-UHFFFAOYSA-N 0.000 claims 1
- CWYSVUXIKXDFMV-UHFFFAOYSA-N 1-[5-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidine-1-carbonyl]thiophen-2-yl]ethanone Chemical compound S1C(C(=O)C)=CC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 CWYSVUXIKXDFMV-UHFFFAOYSA-N 0.000 claims 1
- ILZCDEMKALKKKV-UHFFFAOYSA-N 1-[6-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridin-2-yl]ethanone Chemical compound CC(=O)C1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CN=2)[N+]([O-])=O)=N1 ILZCDEMKALKKKV-UHFFFAOYSA-N 0.000 claims 1
- SBZZNULIMIMELH-UHFFFAOYSA-N 1-methyl-4-[[3-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]phenyl]methyl]piperazine Chemical compound C1CN(C)CCN1CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CN=2)[N+]([O-])=O)=C1 SBZZNULIMIMELH-UHFFFAOYSA-N 0.000 claims 1
- YAERAZRWLRLWSA-UHFFFAOYSA-N 2,2-dimethyl-n-[3-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridin-2-yl]propanamide Chemical compound CC(C)(C)C(=O)NC1=NC=CC=C1C#CC=C1CCN(C=2C(=CC=CN=2)[N+]([O-])=O)CC1 YAERAZRWLRLWSA-UHFFFAOYSA-N 0.000 claims 1
- RWXNALYEOBQGBB-UHFFFAOYSA-N 2,6-difluoro-4-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]benzonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C=C(F)C(C#N)=C(F)C=2)=N1 RWXNALYEOBQGBB-UHFFFAOYSA-N 0.000 claims 1
- WSBIRNRPZGNDLH-UHFFFAOYSA-N 2-(2,5-dimethylpyrrol-1-yl)-5-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]pyrimidine Chemical compound CC1=CC=C(C)N1C1=NC=C(N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)C=N1 WSBIRNRPZGNDLH-UHFFFAOYSA-N 0.000 claims 1
- SQBVNJRZVOEUGT-UHFFFAOYSA-N 2-(3-bromophenoxy)-1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]ethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)COC=2C=C(Br)C=CC=2)=N1 SQBVNJRZVOEUGT-UHFFFAOYSA-N 0.000 claims 1
- HSLNHJUZLXPXEL-UHFFFAOYSA-N 2-(5-bromopyridin-3-yl)-1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]ethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)CC=2C=C(Br)C=NC=2)=N1 HSLNHJUZLXPXEL-UHFFFAOYSA-N 0.000 claims 1
- CUOMNTSAIKIJBC-UHFFFAOYSA-N 2-(5-fluoro-1h-indol-3-yl)-1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]ethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)CC=2C3=CC(F)=CC=C3NC=2)=N1 CUOMNTSAIKIJBC-UHFFFAOYSA-N 0.000 claims 1
- RKKIHUSRIFUDKD-UHFFFAOYSA-N 2-[3-(1-benzylpiperidin-4-ylidene)prop-1-ynyl]-6-methylpyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC=3C=CC=CC=3)CC2)=N1 RKKIHUSRIFUDKD-UHFFFAOYSA-N 0.000 claims 1
- MMLDPNAFXASCHF-UHFFFAOYSA-N 2-[3-(1-benzylsulfonylpiperidin-4-ylidene)prop-1-ynyl]-6-methylpyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)CC=2C=CC=CC=2)=N1 MMLDPNAFXASCHF-UHFFFAOYSA-N 0.000 claims 1
- WUXAVLLPTFDMSH-UHFFFAOYSA-N 2-[3-(1-butylpiperidin-4-ylidene)prop-1-ynyl]-6-methylpyridine Chemical compound C1CN(CCCC)CCC1=CC#CC1=CC=CC(C)=N1 WUXAVLLPTFDMSH-UHFFFAOYSA-N 0.000 claims 1
- DPPGXPBAKZUIKD-UHFFFAOYSA-N 2-[3-[1-(1,2-dimethylimidazol-4-yl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound CN1C(C)=NC(S(=O)(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1 DPPGXPBAKZUIKD-UHFFFAOYSA-N 0.000 claims 1
- RYONOLMMZJYWEO-UHFFFAOYSA-N 2-[3-[1-(3-bromophenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)C=2C=C(Br)C=CC=2)=N1 RYONOLMMZJYWEO-UHFFFAOYSA-N 0.000 claims 1
- NVSICHZSIOZSHP-UHFFFAOYSA-N 2-[3-[1-(4-bromo-2,5-difluorophenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)C=2C(=CC(Br)=C(F)C=2)F)=N1 NVSICHZSIOZSHP-UHFFFAOYSA-N 0.000 claims 1
- CXQAQPXPWJDDEE-UHFFFAOYSA-N 2-[3-[1-(4-bromo-2-fluorophenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)C=2C(=CC(Br)=CC=2)F)=N1 CXQAQPXPWJDDEE-UHFFFAOYSA-N 0.000 claims 1
- OBEIVXMEVXXSDB-UHFFFAOYSA-N 2-[3-[1-(4-methoxy-2-nitrophenyl)piperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 OBEIVXMEVXXSDB-UHFFFAOYSA-N 0.000 claims 1
- ZMSMHRWTKJCWBW-UHFFFAOYSA-N 2-[3-[1-(4-methoxyphenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 ZMSMHRWTKJCWBW-UHFFFAOYSA-N 0.000 claims 1
- WMUJZCZAZKHXRC-UHFFFAOYSA-N 2-[3-[1-(5-chloro-2-methoxy-4-methylphenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound COC1=CC(C)=C(Cl)C=C1S(=O)(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 WMUJZCZAZKHXRC-UHFFFAOYSA-N 0.000 claims 1
- FIRJWXKMAOGSDA-UHFFFAOYSA-N 2-[3-[1-(5-tert-butyl-2-methoxyphenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound COC1=CC=C(C(C)(C)C)C=C1S(=O)(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 FIRJWXKMAOGSDA-UHFFFAOYSA-N 0.000 claims 1
- BKTNVFHODQILHH-UHFFFAOYSA-N 2-[3-[1-(cyclohexylmethylsulfonyl)piperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)CC2CCCCC2)=N1 BKTNVFHODQILHH-UHFFFAOYSA-N 0.000 claims 1
- AQBFXIHCJBUOHU-UHFFFAOYSA-N 2-[3-[1-[(3-fluorophenyl)methylsulfonyl]piperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)CC=2C=C(F)C=CC=2)=N1 AQBFXIHCJBUOHU-UHFFFAOYSA-N 0.000 claims 1
- JARJJPQNEFYJOS-UHFFFAOYSA-N 2-[3-[1-[3-(4-methoxyphenoxy)propylsulfonyl]piperidin-4-ylidene]prop-1-ynyl]-6-methylpyridine Chemical compound C1=CC(OC)=CC=C1OCCCS(=O)(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 JARJJPQNEFYJOS-UHFFFAOYSA-N 0.000 claims 1
- SCMZZIMOZGISTJ-UHFFFAOYSA-N 2-[3-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]phenyl]acetonitrile Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC(CC#N)=C1 SCMZZIMOZGISTJ-UHFFFAOYSA-N 0.000 claims 1
- WXWQDKULMVDHOE-UHFFFAOYSA-N 2-[3-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-3-oxopropyl]isoindole-1,3-dione Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)CCN2C(C3=CC=CC=C3C2=O)=O)=N1 WXWQDKULMVDHOE-UHFFFAOYSA-N 0.000 claims 1
- QYOMJHDREABFBG-UHFFFAOYSA-N 2-[4-[3-(2,3-dimethoxyphenyl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound COC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CN=2)[N+]([O-])=O)=C1OC QYOMJHDREABFBG-UHFFFAOYSA-N 0.000 claims 1
- DIVFIAUUIIXJRU-UHFFFAOYSA-N 2-[4-[3-(2,5-difluorophenyl)prop-2-ynylidene]piperidin-1-yl]-6-methyl-3-nitropyridine Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2C(=CC=C(F)C=2)F)=N1 DIVFIAUUIIXJRU-UHFFFAOYSA-N 0.000 claims 1
- HVXNBXHYCKWDPN-UHFFFAOYSA-N 2-[4-[3-(2,5-difluorophenyl)prop-2-ynylidene]piperidin-1-yl]thiophene-3-carbonitrile Chemical compound FC1=CC=C(F)C(C#CC=C2CCN(CC2)C2=C(C=CS2)C#N)=C1 HVXNBXHYCKWDPN-UHFFFAOYSA-N 0.000 claims 1
- ODULHSXSGVLEOA-UHFFFAOYSA-N 2-[4-[3-(2,6-difluorophenyl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=C(F)C=CC=C1F ODULHSXSGVLEOA-UHFFFAOYSA-N 0.000 claims 1
- XQINHVIPZNATHQ-UHFFFAOYSA-N 2-[4-[3-(2-fluoropyridin-4-yl)prop-2-ynylidene]piperidin-1-yl]-6-methyl-3-nitropyridine Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2C=C(F)N=CC=2)=N1 XQINHVIPZNATHQ-UHFFFAOYSA-N 0.000 claims 1
- UZCSXKMRDRNLST-UHFFFAOYSA-N 2-[4-[3-(2-fluoropyridin-4-yl)prop-2-ynylidene]piperidin-1-yl]-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(N2CCC(CC2)=CC#CC=2C=C(F)N=CC=2)=N1 UZCSXKMRDRNLST-UHFFFAOYSA-N 0.000 claims 1
- CGHFISRUKPLSDK-UHFFFAOYSA-N 2-[4-[3-(3,5-difluoro-4-methoxyphenyl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound C1=C(F)C(OC)=C(F)C=C1C#CC=C1CCN(C=2C(=CC=CN=2)[N+]([O-])=O)CC1 CGHFISRUKPLSDK-UHFFFAOYSA-N 0.000 claims 1
- NGULWAFJRUJLMB-UHFFFAOYSA-N 2-[4-[3-(3,5-difluorophenyl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC(F)=CC(F)=C1 NGULWAFJRUJLMB-UHFFFAOYSA-N 0.000 claims 1
- KGUSAHWXSMCXTC-UHFFFAOYSA-N 2-[4-[3-(3,5-difluorophenyl)prop-2-ynylidene]piperidin-1-yl]-6-methoxy-3-nitropyridine Chemical compound COC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2C=C(F)C=C(F)C=2)=N1 KGUSAHWXSMCXTC-UHFFFAOYSA-N 0.000 claims 1
- ZBZJJZDJKRQTFR-UHFFFAOYSA-N 2-[4-[3-(3,5-difluorophenyl)prop-2-ynylidene]piperidin-1-yl]-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(N2CCC(CC2)=CC#CC=2C=C(F)C=C(F)C=2)=N1 ZBZJJZDJKRQTFR-UHFFFAOYSA-N 0.000 claims 1
- HRZPVGAZESTCHS-UHFFFAOYSA-N 2-[4-[3-(3-bromophenyl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC(Br)=C1 HRZPVGAZESTCHS-UHFFFAOYSA-N 0.000 claims 1
- NTDNSTJWFZRSLJ-UHFFFAOYSA-N 2-[4-[3-(3-chlorophenyl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC(Cl)=C1 NTDNSTJWFZRSLJ-UHFFFAOYSA-N 0.000 claims 1
- KGUIHEYGAPOPIR-UHFFFAOYSA-N 2-[4-[3-(3-ethoxyphenyl)prop-2-ynylidene]piperidin-1-yl]-6-methyl-3-nitropyridine Chemical compound CCOC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=C(C)N=2)[N+]([O-])=O)=C1 KGUIHEYGAPOPIR-UHFFFAOYSA-N 0.000 claims 1
- PISOUGLNLHCPSI-UHFFFAOYSA-N 2-[4-[3-(3-fluorophenyl)prop-2-ynylidene]piperidin-1-yl]-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(N2CCC(CC2)=CC#CC=2C=C(F)C=CC=2)=N1 PISOUGLNLHCPSI-UHFFFAOYSA-N 0.000 claims 1
- FQFPMFCSOAUYCD-UHFFFAOYSA-N 2-[4-[3-(3-methoxyphenyl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound COC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CN=2)[N+]([O-])=O)=C1 FQFPMFCSOAUYCD-UHFFFAOYSA-N 0.000 claims 1
- HCMDIMIQBMBQHW-UHFFFAOYSA-N 2-[4-[3-(3-methoxypyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound COC1=CC=CN=C1C#CC=C1CCN(C=2C(=CC=CN=2)[N+]([O-])=O)CC1 HCMDIMIQBMBQHW-UHFFFAOYSA-N 0.000 claims 1
- ZBOXIAVGEVOBKQ-UHFFFAOYSA-N 2-[4-[3-(3-methylphenyl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CN=2)[N+]([O-])=O)=C1 ZBOXIAVGEVOBKQ-UHFFFAOYSA-N 0.000 claims 1
- ROXWUXRKUFTXFC-UHFFFAOYSA-N 2-[4-[3-(4-fluoropyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-6-methyl-3-nitropyridine Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2N=CC=C(F)C=2)=N1 ROXWUXRKUFTXFC-UHFFFAOYSA-N 0.000 claims 1
- HISYWWLWXUJGDL-UHFFFAOYSA-N 2-[4-[3-(5-cyanopyridin-3-yl)prop-2-ynylidene]piperidin-1-yl]-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(N2CCC(CC2)=CC#CC=2C=C(C=NC=2)C#N)=N1 HISYWWLWXUJGDL-UHFFFAOYSA-N 0.000 claims 1
- JQRHWZCYWSMSAH-UHFFFAOYSA-N 2-[4-[3-(5-fluoropyridin-3-yl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CN=CC(F)=C1 JQRHWZCYWSMSAH-UHFFFAOYSA-N 0.000 claims 1
- PKPTXNDKQQPOHJ-UHFFFAOYSA-N 2-[4-[3-(5-fluoropyridin-3-yl)prop-2-ynylidene]piperidin-1-yl]-6-methyl-3-nitropyridine Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2C=C(F)C=NC=2)=N1 PKPTXNDKQQPOHJ-UHFFFAOYSA-N 0.000 claims 1
- XYAPYLIGAXZLRM-UHFFFAOYSA-N 2-[4-[3-(6-bromopyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-6-methyl-3-nitropyridine Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2N=C(Br)C=CC=2)=N1 XYAPYLIGAXZLRM-UHFFFAOYSA-N 0.000 claims 1
- JTGIVTUWCAXKMD-UHFFFAOYSA-N 2-[4-[3-(6-fluoropyridin-3-yl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=C(F)N=C1 JTGIVTUWCAXKMD-UHFFFAOYSA-N 0.000 claims 1
- UTGAMTZPEISTHM-UHFFFAOYSA-N 2-[4-[3-(6-fluoropyridin-3-yl)prop-2-ynylidene]piperidin-1-yl]-6-methyl-3-nitropyridine Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2C=NC(F)=CC=2)=N1 UTGAMTZPEISTHM-UHFFFAOYSA-N 0.000 claims 1
- ZWAPUKFIZBIQDS-UHFFFAOYSA-N 2-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]benzonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CC=2)C#N)=N1 ZWAPUKFIZBIQDS-UHFFFAOYSA-N 0.000 claims 1
- JLFTXTPXQUMNQA-UHFFFAOYSA-N 2-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]thiophene-3-carbonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C2=C(C=CS2)C#N)=N1 JLFTXTPXQUMNQA-UHFFFAOYSA-N 0.000 claims 1
- RBJYGZUFTCRCJP-UHFFFAOYSA-N 2-ethoxy-3-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CCOC1=NC=CC=C1C#CC=C1CCN(C=2C(=CC=CN=2)[N+]([O-])=O)CC1 RBJYGZUFTCRCJP-UHFFFAOYSA-N 0.000 claims 1
- MXSHWGPDMSWIMQ-UHFFFAOYSA-N 2-ethoxy-5-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]pyridine Chemical compound C1=NC(OCC)=CC=C1N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 MXSHWGPDMSWIMQ-UHFFFAOYSA-N 0.000 claims 1
- HFTPTBNENZNIQZ-UHFFFAOYSA-N 2-fluoro-4-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]benzonitrile Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=C(C#N)C(F)=C1 HFTPTBNENZNIQZ-UHFFFAOYSA-N 0.000 claims 1
- SFKPHIIQVWZOFR-UHFFFAOYSA-N 2-fluoro-6-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC(F)=N1 SFKPHIIQVWZOFR-UHFFFAOYSA-N 0.000 claims 1
- FZPNCLKLGWVCNB-UHFFFAOYSA-N 2-fluoro-6-methyl-3-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound FC1=NC(C)=CC=C1C#CC=C1CCN(C=2C(=CC=CN=2)[N+]([O-])=O)CC1 FZPNCLKLGWVCNB-UHFFFAOYSA-N 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- MYBIEXFXZYSVQH-UHFFFAOYSA-N 2-methyl-4-(3-piperidin-4-ylideneprop-1-ynyl)-1,3-thiazole Chemical compound S1C(C)=NC(C#CC=C2CCNCC2)=C1 MYBIEXFXZYSVQH-UHFFFAOYSA-N 0.000 claims 1
- XAWKEEJDXQLANC-UHFFFAOYSA-N 2-methyl-6-(3-piperidin-4-ylideneprop-1-ynyl)pyridine Chemical compound CC1=CC=CC(C#CC=C2CCNCC2)=N1 XAWKEEJDXQLANC-UHFFFAOYSA-N 0.000 claims 1
- XDPFGJXAVSHFAW-UHFFFAOYSA-N 2-methyl-6-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]hex-1-en-4-yn-3-one Chemical compound C1CC(=CC#CC(=O)C(=C)C)CCN1C1=NC=CC=C1[N+]([O-])=O XDPFGJXAVSHFAW-UHFFFAOYSA-N 0.000 claims 1
- PGDZTLDIKMARHN-UHFFFAOYSA-N 2-methyl-6-[3-(1-phenylpiperidin-4-ylidene)prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C=CC=CC=2)=N1 PGDZTLDIKMARHN-UHFFFAOYSA-N 0.000 claims 1
- KQFDZEJNJKCORK-UHFFFAOYSA-N 2-methyl-6-[3-[1-(2,2,2-trifluoroethylsulfonyl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)CC(F)(F)F)=N1 KQFDZEJNJKCORK-UHFFFAOYSA-N 0.000 claims 1
- ISJGFEZRLIFJLL-UHFFFAOYSA-N 2-methyl-6-[3-[1-(2-methyl-5-nitro-1h-imidazol-4-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound N1C(C)=NC([N+]([O-])=O)=C1N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 ISJGFEZRLIFJLL-UHFFFAOYSA-N 0.000 claims 1
- GTADKUQSONAGQH-UHFFFAOYSA-N 2-methyl-6-[3-[1-(2-nitrophenyl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CC=2)[N+]([O-])=O)=N1 GTADKUQSONAGQH-UHFFFAOYSA-N 0.000 claims 1
- ZPALGXFNRJTZFY-UHFFFAOYSA-N 2-methyl-6-[3-[1-(2-nitrophenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=N1 ZPALGXFNRJTZFY-UHFFFAOYSA-N 0.000 claims 1
- UPMZLJKBTTYELB-UHFFFAOYSA-N 2-methyl-6-[3-[1-(2-propoxypyridin-3-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CCCOC1=NC=CC=C1N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 UPMZLJKBTTYELB-UHFFFAOYSA-N 0.000 claims 1
- NUGVOIODJYKXMA-UHFFFAOYSA-N 2-methyl-6-[3-[1-(3-methyl-5-nitroimidazol-4-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2N(C=NC=2[N+]([O-])=O)C)=N1 NUGVOIODJYKXMA-UHFFFAOYSA-N 0.000 claims 1
- WYDQDVYUIYFOCH-UHFFFAOYSA-N 2-methyl-6-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CN=2)[N+]([O-])=O)=N1 WYDQDVYUIYFOCH-UHFFFAOYSA-N 0.000 claims 1
- CMCAPUCLEBUSFX-UHFFFAOYSA-N 2-methyl-6-[3-[1-(3-nitrothiophen-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C2=C(C=CS2)[N+]([O-])=O)=N1 CMCAPUCLEBUSFX-UHFFFAOYSA-N 0.000 claims 1
- FZKKRTPKKMCTAP-UHFFFAOYSA-N 2-methyl-6-[3-[1-(4-methyl-3-nitrophenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)C=2C=C(C(C)=CC=2)[N+]([O-])=O)=N1 FZKKRTPKKMCTAP-UHFFFAOYSA-N 0.000 claims 1
- MSTJOBPAXRNQDB-UHFFFAOYSA-N 2-methyl-6-[3-[1-(4-methylphenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 MSTJOBPAXRNQDB-UHFFFAOYSA-N 0.000 claims 1
- QPZYAQBCKBBTPU-UHFFFAOYSA-N 2-methyl-6-[3-[1-(4-methylpyridin-3-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=NC=2)C)=N1 QPZYAQBCKBBTPU-UHFFFAOYSA-N 0.000 claims 1
- DKWYSUSWAFPVPE-UHFFFAOYSA-N 2-methyl-6-[3-[1-(4-propan-2-ylphenyl)sulfonylpiperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound C1=CC(C(C)C)=CC=C1S(=O)(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 DKWYSUSWAFPVPE-UHFFFAOYSA-N 0.000 claims 1
- OJMYCYWSXGQYPW-UHFFFAOYSA-N 2-methyl-6-[3-[1-(5-methyl-2-nitrophenyl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1 OJMYCYWSXGQYPW-UHFFFAOYSA-N 0.000 claims 1
- FHOYVKUYOMYYOM-UHFFFAOYSA-N 2-methyl-6-[3-[1-(5-nitro-1h-imidazol-4-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C2=C(N=CN2)[N+]([O-])=O)=N1 FHOYVKUYOMYYOM-UHFFFAOYSA-N 0.000 claims 1
- RZRGCEIUNFCTJH-UHFFFAOYSA-N 2-methyl-6-[3-[1-(5-nitrofuran-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2OC(=CC=2)[N+]([O-])=O)=N1 RZRGCEIUNFCTJH-UHFFFAOYSA-N 0.000 claims 1
- LAHVQCPUQMBWLF-UHFFFAOYSA-N 2-methyl-6-[3-[1-(5-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2N=CC(=CC=2)[N+]([O-])=O)=N1 LAHVQCPUQMBWLF-UHFFFAOYSA-N 0.000 claims 1
- DGQSHFYZRKAYON-UHFFFAOYSA-N 2-methyl-6-[3-[1-[5-(trifluoromethyl)pyridin-3-yl]piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C=C(C=NC=2)C(F)(F)F)=N1 DGQSHFYZRKAYON-UHFFFAOYSA-N 0.000 claims 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- HKQCSOHYRBSTFD-UHFFFAOYSA-N 3,3-dimethyl-1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]butan-1-one Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)CC(C)(C)C)=N1 HKQCSOHYRBSTFD-UHFFFAOYSA-N 0.000 claims 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims 1
- RRMWIPHPNQKQBE-UHFFFAOYSA-N 3-(3-fluorophenoxy)-1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]propan-1-one Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)CCOC=2C=C(F)C=CC=2)=N1 RRMWIPHPNQKQBE-UHFFFAOYSA-N 0.000 claims 1
- IRKAGJVESAWXEL-UHFFFAOYSA-N 3-(4-chlorophenyl)-5-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-5-oxopentanamide Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)CC(CC(N)=O)C=2C=CC(Cl)=CC=2)=N1 IRKAGJVESAWXEL-UHFFFAOYSA-N 0.000 claims 1
- ZEMJGZVAWWXEGI-UHFFFAOYSA-N 3-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]benzonitrile Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC(C#N)=C1 ZEMJGZVAWWXEGI-UHFFFAOYSA-N 0.000 claims 1
- GUOKWUACIDBXLY-UHFFFAOYSA-N 3-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]quinoline Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CN=C(C=CC=C2)C2=C1 GUOKWUACIDBXLY-UHFFFAOYSA-N 0.000 claims 1
- UMMKJCGEDFSTGQ-UHFFFAOYSA-N 3-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]pyrazine-2-carbonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=NC=CN=2)C#N)=N1 UMMKJCGEDFSTGQ-UHFFFAOYSA-N 0.000 claims 1
- XHCSNEWRSXEHRX-UHFFFAOYSA-N 3-bromo-2-chloro-4-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=NC(Cl)=C1Br XHCSNEWRSXEHRX-UHFFFAOYSA-N 0.000 claims 1
- BYKZOGFFWVROTG-UHFFFAOYSA-N 3-bromo-2-fluoro-4-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=NC(F)=C1Br BYKZOGFFWVROTG-UHFFFAOYSA-N 0.000 claims 1
- WTIJEXPUOMHIKV-UHFFFAOYSA-N 3-chloro-4-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]sulfonylbenzonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)C=2C(=CC(=CC=2)C#N)Cl)=N1 WTIJEXPUOMHIKV-UHFFFAOYSA-N 0.000 claims 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 1
- LEVRBWQHTUZHGP-UHFFFAOYSA-N 3-methyl-2-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-5-nitropyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC(=CN=2)[N+]([O-])=O)C)=N1 LEVRBWQHTUZHGP-UHFFFAOYSA-N 0.000 claims 1
- BMQPCJQUEGGXGX-UHFFFAOYSA-N 3-methyl-5-[3-[3-[1-(6-methyl-3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]phenyl]-1,2,4-oxadiazole Chemical compound CC1=NOC(C=2C=C(C=CC=2)C#CC=C2CCN(CC2)C=2C(=CC=C(C)N=2)[N+]([O-])=O)=N1 BMQPCJQUEGGXGX-UHFFFAOYSA-N 0.000 claims 1
- YATZGLPZEVHKJR-UHFFFAOYSA-N 3-nitro-2-[4-(3-phenylprop-2-ynylidene)piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC=C1 YATZGLPZEVHKJR-UHFFFAOYSA-N 0.000 claims 1
- YFKGKOJKLVSGSA-UHFFFAOYSA-N 3-nitro-2-[4-(3-pyridin-2-ylprop-2-ynylidene)piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC=N1 YFKGKOJKLVSGSA-UHFFFAOYSA-N 0.000 claims 1
- DKOLFWMCGZPRPC-UHFFFAOYSA-N 3-nitro-2-[4-(3-pyridin-3-ylprop-2-ynylidene)piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CN=C1 DKOLFWMCGZPRPC-UHFFFAOYSA-N 0.000 claims 1
- UGXUMYCOYXNGCX-UHFFFAOYSA-N 3-nitro-2-[4-(3-pyridin-4-ylprop-2-ynylidene)piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=NC=C1 UGXUMYCOYXNGCX-UHFFFAOYSA-N 0.000 claims 1
- QVPWQOAKUYWDRJ-UHFFFAOYSA-N 3-nitro-2-[4-(4-phenylbut-3-yn-2-ylidene)piperidin-1-yl]pyridine Chemical compound C1CN(C=2C(=CC=CN=2)[N+]([O-])=O)CCC1=C(C)C#CC1=CC=CC=C1 QVPWQOAKUYWDRJ-UHFFFAOYSA-N 0.000 claims 1
- FLSGKVGAMDJYPL-XBXARRHUSA-N 3-nitro-2-[4-[(e)-3-phenylprop-2-enylidene]piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=C\C=C\C1=CC=CC=C1 FLSGKVGAMDJYPL-XBXARRHUSA-N 0.000 claims 1
- LMGASOLCFCTEHQ-UHFFFAOYSA-N 3-nitro-2-[4-[3-(3-nitrophenyl)prop-2-ynylidene]piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=CN=2)[N+]([O-])=O)=C1 LMGASOLCFCTEHQ-UHFFFAOYSA-N 0.000 claims 1
- PIRFRBWOCLKSIW-UHFFFAOYSA-N 3-nitro-2-[4-[3-[3-(trifluoromethoxy)phenyl]prop-2-ynylidene]piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC(OC(F)(F)F)=C1 PIRFRBWOCLKSIW-UHFFFAOYSA-N 0.000 claims 1
- YZNVODQNWPMROS-UHFFFAOYSA-N 3-nitro-2-[4-[3-[3-(trifluoromethyl)phenyl]prop-2-ynylidene]piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=CC(C(F)(F)F)=C1 YZNVODQNWPMROS-UHFFFAOYSA-N 0.000 claims 1
- PXCAFAOYNODBJQ-UHFFFAOYSA-N 3-nitro-2-[4-[3-[4-(pyrrolidin-1-ylmethyl)phenyl]prop-2-ynylidene]piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC(C=C1)=CC=C1CN1CCCC1 PXCAFAOYNODBJQ-UHFFFAOYSA-N 0.000 claims 1
- LTBHQLDFHLVSLR-UHFFFAOYSA-N 3-nitro-2-[4-[3-[6-(trifluoromethyl)pyridin-3-yl]prop-2-ynylidene]piperidin-1-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=C(C(F)(F)F)N=C1 LTBHQLDFHLVSLR-UHFFFAOYSA-N 0.000 claims 1
- FFHJMLIUFNHAFG-UHFFFAOYSA-N 4,4,4-trifluoro-1-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]butan-1-one Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)CCC(F)(F)F)=N1 FFHJMLIUFNHAFG-UHFFFAOYSA-N 0.000 claims 1
- QOAKDICTMMJSLE-UHFFFAOYSA-N 4-[3-(3,5-difluorophenyl)prop-2-ynylidene]-1-(3-methyl-5-nitroimidazol-4-yl)piperidine Chemical compound CN1C=NC([N+]([O-])=O)=C1N(CC1)CCC1=CC#CC1=CC(F)=CC(F)=C1 QOAKDICTMMJSLE-UHFFFAOYSA-N 0.000 claims 1
- FNHKUHMKWHDZML-UHFFFAOYSA-N 4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]-n-(1-phenylethyl)piperidine-1-carboxamide Chemical compound C=1C=CC=CC=1C(C)NC(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 FNHKUHMKWHDZML-UHFFFAOYSA-N 0.000 claims 1
- OKCFWFMZHQESJA-UHFFFAOYSA-N 4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]-n-(3-nitrophenyl)piperidine-1-carboxamide Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)NC=2C=C(C=CC=2)[N+]([O-])=O)=N1 OKCFWFMZHQESJA-UHFFFAOYSA-N 0.000 claims 1
- SOAOIVIWLZTDCK-UHFFFAOYSA-N 4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]-n-phenylpiperidine-1-carboxamide Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)NC=2C=CC=CC=2)=N1 SOAOIVIWLZTDCK-UHFFFAOYSA-N 0.000 claims 1
- BVZYIHLCSXLCKH-UHFFFAOYSA-N 4-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]benzonitrile Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=C(C#N)C=C1 BVZYIHLCSXLCKH-UHFFFAOYSA-N 0.000 claims 1
- GQGVLWOVMIWXOA-UHFFFAOYSA-N 4-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-3-nitrobenzonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC(=CC=2)C#N)[N+]([O-])=O)=N1 GQGVLWOVMIWXOA-UHFFFAOYSA-N 0.000 claims 1
- TYXJCSZNKVHNQT-UHFFFAOYSA-N 4-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]isoquinoline Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C3=CC=CC=C3C=NC=2)=N1 TYXJCSZNKVHNQT-UHFFFAOYSA-N 0.000 claims 1
- WIMAOYKTRDAVHF-UHFFFAOYSA-N 4-[4-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]sulfonylphenyl]thiadiazole Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)C=2C=CC(=CC=2)C=2N=NSC=2)=N1 WIMAOYKTRDAVHF-UHFFFAOYSA-N 0.000 claims 1
- VNJCGBHVKVRDEZ-UHFFFAOYSA-N 4-[5-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridin-2-yl]morpholine Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=C(N2CCOCC2)N=C1 VNJCGBHVKVRDEZ-UHFFFAOYSA-N 0.000 claims 1
- NIEOTBBFKLWLQZ-UHFFFAOYSA-N 4-bromo-2-fluoro-6-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]benzonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=C(F)C=C(Br)C=2)C#N)=N1 NIEOTBBFKLWLQZ-UHFFFAOYSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- IIUXCODZVSWOQO-UHFFFAOYSA-N 4-methoxy-3-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]benzonitrile Chemical compound COC1=CC=C(C#N)C=C1N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 IIUXCODZVSWOQO-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- AQYQPGZYZNZCFD-UHFFFAOYSA-N 5-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine-2-carbonitrile Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=C(C#N)N=C1 AQYQPGZYZNZCFD-UHFFFAOYSA-N 0.000 claims 1
- QQQPJXWNAUDUDO-UHFFFAOYSA-N 5-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CN=CC(C#N)=C1 QQQPJXWNAUDUDO-UHFFFAOYSA-N 0.000 claims 1
- XNOQXHMGQKGLSV-UHFFFAOYSA-N 5-[3-[1-(6-methyl-3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]pyridine-3-carbonitrile Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2C=C(C=NC=2)C#N)=N1 XNOQXHMGQKGLSV-UHFFFAOYSA-N 0.000 claims 1
- UASARKLMFIXDLW-UHFFFAOYSA-N 5-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-n-phenylfuran-2-carboxamide Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2OC(=CC=2)C(=O)NC=2C=CC=CC=2)=N1 UASARKLMFIXDLW-UHFFFAOYSA-N 0.000 claims 1
- WZRYXUDNMYMCJC-UHFFFAOYSA-N 5-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]pyridine-2-carbonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C=NC(=CC=2)C#N)=N1 WZRYXUDNMYMCJC-UHFFFAOYSA-N 0.000 claims 1
- HWMMKRBEDIBLJG-UHFFFAOYSA-N 5-bromo-2-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]pyrimidine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2N=CC(Br)=CN=2)=N1 HWMMKRBEDIBLJG-UHFFFAOYSA-N 0.000 claims 1
- GZJOGCXNYLOGGU-UHFFFAOYSA-N 5-methyl-6-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]pyridine-3-carbonitrile Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC(=CN=2)C#N)C)=N1 GZJOGCXNYLOGGU-UHFFFAOYSA-N 0.000 claims 1
- ARBPJODSURMBJE-UHFFFAOYSA-N 6-[3-[1-(3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]quinoxaline Chemical compound [O-][N+](=O)C1=CC=CN=C1N(CC1)CCC1=CC#CC1=CC=C(N=CC=N2)C2=C1 ARBPJODSURMBJE-UHFFFAOYSA-N 0.000 claims 1
- AQTHFSUSNDFPPG-UHFFFAOYSA-N 6-chloro-5-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]sulfonylimidazo[2,1-b][1,3]thiazole Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)C=2N3C=CSC3=NC=2Cl)=N1 AQTHFSUSNDFPPG-UHFFFAOYSA-N 0.000 claims 1
- NKAMGKJRSCXTMZ-UHFFFAOYSA-N 6-methoxy-2-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound COC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=N1 NKAMGKJRSCXTMZ-UHFFFAOYSA-N 0.000 claims 1
- NQDVPJBFJIXQOL-REZTVBANSA-N 6-methyl-2-[(3e)-3-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound CC1=CC=CC(C#C\C=C/2CN(CCC\2)C=2C(=CC=C(C)N=2)[N+]([O-])=O)=N1 NQDVPJBFJIXQOL-REZTVBANSA-N 0.000 claims 1
- PBXOXSPYYDJBIS-UHFFFAOYSA-N 6-methyl-2-[4-(3-pyridin-4-ylprop-2-ynylidene)piperidin-1-yl]pyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(N2CCC(CC2)=CC#CC=2C=CN=CC=2)=N1 PBXOXSPYYDJBIS-UHFFFAOYSA-N 0.000 claims 1
- HUXAEZZYYHMSFH-UHFFFAOYSA-N 6-methyl-2-[4-(4-phenylbut-3-yn-2-ylidene)piperidin-1-yl]pyridine-3-carbonitrile Chemical compound C1CN(C=2C(=CC=C(C)N=2)C#N)CCC1=C(C)C#CC1=CC=CC=C1 HUXAEZZYYHMSFH-UHFFFAOYSA-N 0.000 claims 1
- PMZOHLAAOGMACN-UHFFFAOYSA-N 6-methyl-2-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-3-nitropyridine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=C(C)N=2)[N+]([O-])=O)=N1 PMZOHLAAOGMACN-UHFFFAOYSA-N 0.000 claims 1
- ARRAMCZKNYKANU-UHFFFAOYSA-N 6-methyl-3-nitro-2-[4-(3-pyridin-2-ylprop-2-ynylidene)piperidin-1-yl]pyridine Chemical compound CC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)=CC#CC=2N=CC=CC=2)=N1 ARRAMCZKNYKANU-UHFFFAOYSA-N 0.000 claims 1
- QQCKJNQQJDWNHE-UHFFFAOYSA-N 6-methyl-3-nitro-2-[4-(4-phenylbut-3-yn-2-ylidene)piperidin-1-yl]pyridine Chemical compound C1CN(C=2C(=CC=C(C)N=2)[N+]([O-])=O)CCC1=C(C)C#CC1=CC=CC=C1 QQCKJNQQJDWNHE-UHFFFAOYSA-N 0.000 claims 1
- CVWKFGBEJQTHIB-UHFFFAOYSA-N 7,7-dimethyl-4-[[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]sulfonylmethyl]bicyclo[2.2.1]heptan-3-one Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)S(=O)(=O)CC23C(CC(CC2)C3(C)C)=O)=N1 CVWKFGBEJQTHIB-UHFFFAOYSA-N 0.000 claims 1
- CBYFZHYCFSQIDX-UHFFFAOYSA-N 7-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]pyrido[2,3-b]pyrazine Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C=2C=C3N=CC=NC3=NC=2)=N1 CBYFZHYCFSQIDX-UHFFFAOYSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- WXXDUGGITYSMIW-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1(C(=O)N2CCC(CC2)=CC#CC2=NC(=CC=C2)C)CC=CC=C1 Chemical compound C(C1=CC=CC=C1)OC1(C(=O)N2CCC(CC2)=CC#CC2=NC(=CC=C2)C)CC=CC=C1 WXXDUGGITYSMIW-UHFFFAOYSA-N 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- XUSJSBKWLMAFED-UHFFFAOYSA-N [1-(4-fluorophenyl)-5-methyl-1,2,4-triazol-3-yl]-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=NC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=NN1C1=CC=C(F)C=C1 XUSJSBKWLMAFED-UHFFFAOYSA-N 0.000 claims 1
- BYVWGMDPXMUHMR-UHFFFAOYSA-N [3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=N1 BYVWGMDPXMUHMR-UHFFFAOYSA-N 0.000 claims 1
- JXILCLCUWHQEMI-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(1-pyridin-4-ylpiperidin-4-yl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C2CCN(CC2)C=2C=CN=CC=2)=N1 JXILCLCUWHQEMI-UHFFFAOYSA-N 0.000 claims 1
- DPTMAIFCOKWERF-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(2-nitrophenyl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=N1 DPTMAIFCOKWERF-UHFFFAOYSA-N 0.000 claims 1
- ZQSWDMXSLGRRTI-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1 ZQSWDMXSLGRRTI-UHFFFAOYSA-N 0.000 claims 1
- GMSHAPLQYPRIQX-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(3-nitrophenyl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(C=CC=2)[N+]([O-])=O)=N1 GMSHAPLQYPRIQX-UHFFFAOYSA-N 0.000 claims 1
- ZEBDEDZCTSIVCE-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(3-phenylphenyl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(C=CC=2)C=2C=CC=CC=2)=N1 ZEBDEDZCTSIVCE-UHFFFAOYSA-N 0.000 claims 1
- ZGCJBJONYYGXIB-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(4-methylthiophen-2-yl)methanone Chemical compound CC1=CSC(C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1 ZGCJBJONYYGXIB-UHFFFAOYSA-N 0.000 claims 1
- OIWATMRSSPKULK-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(4-nitrophenyl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=N1 OIWATMRSSPKULK-UHFFFAOYSA-N 0.000 claims 1
- QPPKVXXPSXYCOS-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(5-methylsulfanylthiophen-2-yl)methanone Chemical compound S1C(SC)=CC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 QPPKVXXPSXYCOS-UHFFFAOYSA-N 0.000 claims 1
- LJNIRVWQHRMFEI-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(5-methylthiophen-2-yl)methanone Chemical compound S1C(C)=CC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 LJNIRVWQHRMFEI-UHFFFAOYSA-N 0.000 claims 1
- ASSOHBBUIONVNQ-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(5-nitrofuran-2-yl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2OC(=CC=2)[N+]([O-])=O)=N1 ASSOHBBUIONVNQ-UHFFFAOYSA-N 0.000 claims 1
- ZXNQPWOFYGZUQF-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(5-nitrothiophen-2-yl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2SC(=CC=2)[N+]([O-])=O)=N1 ZXNQPWOFYGZUQF-UHFFFAOYSA-N 0.000 claims 1
- VZAGGTLNLVCVBF-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(5-phenylfuran-2-yl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2OC(=CC=2)C=2C=CC=CC=2)=N1 VZAGGTLNLVCVBF-UHFFFAOYSA-N 0.000 claims 1
- XGVYHZOHXQQZSG-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-(5-thiophen-2-yl-1h-pyrazol-3-yl)methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C2=NNC(=C2)C=2SC=CC=2)=N1 XGVYHZOHXQQZSG-UHFFFAOYSA-N 0.000 claims 1
- VNQHLIRSXYQCCG-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-[3-(2-methyl-1,3-thiazol-4-yl)phenyl]methanone Chemical compound S1C(C)=NC(C=2C=C(C=CC=2)C(=O)N2CCC(CC2)=CC#CC=2N=C(C)C=CC=2)=C1 VNQHLIRSXYQCCG-UHFFFAOYSA-N 0.000 claims 1
- QFJXHRJTLUMDBG-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-[3-(trifluoromethoxy)phenyl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(OC(F)(F)F)C=CC=2)=N1 QFJXHRJTLUMDBG-UHFFFAOYSA-N 0.000 claims 1
- NCNWJPDTELTZOW-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-[3-(trifluoromethyl)phenyl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=C(C=CC=2)C(F)(F)F)=N1 NCNWJPDTELTZOW-UHFFFAOYSA-N 0.000 claims 1
- KTCGQWRXWWYVAJ-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-morpholin-4-ylmethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)N2CCOCC2)=N1 KTCGQWRXWWYVAJ-UHFFFAOYSA-N 0.000 claims 1
- CUGQIYJEIVMVKC-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-phenylmethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C=CC=CC=2)=N1 CUGQIYJEIVMVKC-UHFFFAOYSA-N 0.000 claims 1
- NBKOCVUIYDWMRL-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-pyrazin-2-ylmethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2N=CC=NC=2)=N1 NBKOCVUIYDWMRL-UHFFFAOYSA-N 0.000 claims 1
- DVPFYKUJMQHPHK-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-quinolin-5-ylmethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2C3=CC=CN=C3C=CC=2)=N1 DVPFYKUJMQHPHK-UHFFFAOYSA-N 0.000 claims 1
- GXMCUJJLTGZBHC-UHFFFAOYSA-N [4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]-thiophen-2-ylmethanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2SC=CC=2)=N1 GXMCUJJLTGZBHC-UHFFFAOYSA-N 0.000 claims 1
- CWSRVGAEIFSCDS-UHFFFAOYSA-N [5-(furan-2-yl)-1h-pyrazol-3-yl]-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C2=NNC(=C2)C=2OC=CC=2)=N1 CWSRVGAEIFSCDS-UHFFFAOYSA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 150000001602 bicycloalkyls Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- VAJCYEPHIUALRR-UHFFFAOYSA-N furan-2-yl-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C=2OC=CC=2)=N1 VAJCYEPHIUALRR-UHFFFAOYSA-N 0.000 claims 1
- BHFJRTSHKMYHMP-UHFFFAOYSA-N furan-3-yl-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidin-1-yl]methanone Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)C2=COC=C2)=N1 BHFJRTSHKMYHMP-UHFFFAOYSA-N 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000005946 imidazo[1,2-a]pyridyl group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000005956 isoquinolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- BKRZKXKTTVSPMQ-UHFFFAOYSA-N n-[3-[3-[1-(6-methyl-3-nitropyridin-2-yl)piperidin-4-ylidene]prop-1-ynyl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(C#CC=C2CCN(CC2)C=2C(=CC=C(C)N=2)[N+]([O-])=O)=C1 BKRZKXKTTVSPMQ-UHFFFAOYSA-N 0.000 claims 1
- OKYDXDNNCGRANO-UHFFFAOYSA-N n-[3-methyl-4-[4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidine-1-carbonyl]phenyl]acetamide Chemical compound CC1=CC(NC(=O)C)=CC=C1C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 OKYDXDNNCGRANO-UHFFFAOYSA-N 0.000 claims 1
- DUDLUGRLTVPTNX-UHFFFAOYSA-N n-butyl-n-methyl-4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidine-1-carboxamide Chemical compound C1CN(C(=O)N(C)CCCC)CCC1=CC#CC1=CC=CC(C)=N1 DUDLUGRLTVPTNX-UHFFFAOYSA-N 0.000 claims 1
- IWRIPKVWTDSOGO-UHFFFAOYSA-N n-ethyl-4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]-n-propan-2-ylpiperidine-1-carboxamide Chemical compound C1CN(C(=O)N(C(C)C)CC)CCC1=CC#CC1=CC=CC(C)=N1 IWRIPKVWTDSOGO-UHFFFAOYSA-N 0.000 claims 1
- ROVCWFANMYKPDP-UHFFFAOYSA-N n-ethyl-4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidine-1-carboxamide Chemical compound C1CN(C(=O)NCC)CCC1=CC#CC1=CC=CC(C)=N1 ROVCWFANMYKPDP-UHFFFAOYSA-N 0.000 claims 1
- FRFZTKDETHKTJK-UHFFFAOYSA-N n-methyl-4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]-n-(1-phenylethyl)piperidine-1-carboxamide Chemical compound C=1C=CC=CC=1C(C)N(C)C(=O)N(CC1)CCC1=CC#CC1=CC=CC(C)=N1 FRFZTKDETHKTJK-UHFFFAOYSA-N 0.000 claims 1
- WIEGOXMITHQIFN-UHFFFAOYSA-N n-tert-butyl-4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidine-1-carboxamide Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)NC(C)(C)C)=N1 WIEGOXMITHQIFN-UHFFFAOYSA-N 0.000 claims 1
- MBRQXVVRMDOUAR-UHFFFAOYSA-N n-tert-butyl-n-methyl-4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidine-1-carboxamide Chemical compound C1CN(C(=O)N(C)C(C)(C)C)CCC1=CC#CC1=CC=CC(C)=N1 MBRQXVVRMDOUAR-UHFFFAOYSA-N 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000005936 piperidyl group Chemical group 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- WXAFGKCDPPURIY-OVCLIPMQSA-N tert-butyl (3e)-3-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]pyrrolidine-1-carboxylate Chemical compound CC1=CC=CC(C#C\C=C/2CN(CC\2)C(=O)OC(C)(C)C)=N1 WXAFGKCDPPURIY-OVCLIPMQSA-N 0.000 claims 1
- IKRVLBVMHXLPCV-UHFFFAOYSA-N tert-butyl 4-[3-(2-methyl-1,3-thiazol-4-yl)prop-2-ynylidene]piperidine-1-carboxylate Chemical compound S1C(C)=NC(C#CC=C2CCN(CC2)C(=O)OC(C)(C)C)=C1 IKRVLBVMHXLPCV-UHFFFAOYSA-N 0.000 claims 1
- ZTLRBCFUYXAZHX-UHFFFAOYSA-N tert-butyl 4-[3-(5-cyanopyridin-3-yl)prop-2-ynylidene]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1=CC#CC1=CN=CC(C#N)=C1 ZTLRBCFUYXAZHX-UHFFFAOYSA-N 0.000 claims 1
- ZVEKZOGFOKOTDI-UHFFFAOYSA-N tert-butyl 4-[3-(6-cyanopyridin-3-yl)prop-2-ynylidene]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1=CC#CC1=CC=C(C#N)N=C1 ZVEKZOGFOKOTDI-UHFFFAOYSA-N 0.000 claims 1
- YKAWLNCHRFKROH-UHFFFAOYSA-N tert-butyl 4-[3-(6-methylpyridin-2-yl)prop-2-ynylidene]piperidine-1-carboxylate Chemical compound CC1=CC=CC(C#CC=C2CCN(CC2)C(=O)OC(C)(C)C)=N1 YKAWLNCHRFKROH-UHFFFAOYSA-N 0.000 claims 1
- OYMKRMUFADAJSN-UHFFFAOYSA-N tert-butyl 4-hept-2-ynylidenepiperidine-1-carboxylate Chemical compound CCCCC#CC=C1CCN(C(=O)OC(C)(C)C)CC1 OYMKRMUFADAJSN-UHFFFAOYSA-N 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 101001032845 Homo sapiens Metabotropic glutamate receptor 5 Proteins 0.000 abstract 1
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000026723 Urinary tract disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 102000006239 metabotropic receptors Human genes 0.000 abstract 1
- 108020004083 metabotropic receptors Proteins 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002232 neuromuscular Effects 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 208000014001 urinary system disease Diseases 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Spoj koji ima opću formulu IgdjeZ predstavlja skupinu formule -C?C-R2 ili -CH=CH-R2;R1 predstavljaatom vodika ili halogena, ilihidroksi, cijano, C1-C6alkil, C1-C6 alkilkarbonil, C1-C6 alkoksi, C1-C6 alkoksikarbonil, C1-C6 alkilkarboniloksi, C1-C6 alkoksikarboniloksi, C1-C6 alkiltio, di-(C1-C6 alkil)-amino ili C3-C14 cikloalkil grupu; R2 predstavljaopcijski supstituiranu mono- ili biciklo C1-C9 heterocikličnu skupinu koja sadrži od 1 do 3 heteroatoma izabrana od dušika, kisika i sumpora. opcijski supstituiranu mono-, bi- ili tricikličnu C6-C14 aril skupinu, opcijski supstituiranu C1-C6 alkil skupinu, opcijski supstituiranu C2-C6 alkilenil skupinu iliopcijski supstituiranu C3-C6 cikloalkil skupinu, ili R2 predstavlja skupinu -C(O)-R2A, gdje je R2A definiran kao gore R2;R3 predstavljaatom vodika, opcijski supstituiranu C1-C6 alkil skupinu, opcijski supstituiranu mono-, bi- ili tricikličnu C1-C14 heterocikličnu skupinu koja sadrži 1 do 3 heteroatoma izabrana od dušika, kisika i sumpora, opcijski supstituiranu mono, bi ili tricikličnu C6-C14 aril skupinu, opcijski supstituiranu C3-C6 cikloalkil skupinu iliopcijski supstituiranu C3-C6 cikloalkenil skupinu, Y predstavlja skupinu formule -C(O)-, -C(S)-, -NH-C(O)-, -N(C1-C6 alkil)-C(O)-, -O-C(O)-, -NH-C(S)-, -N(C1-C6 alkil)-C(S)-, -O-C(S)- ili -SO2- ili je odsutan, m je 0, 1 ili 2; n je 0, 1 ili 2; supstituenti za svaku opcijski supstituiranu skupinu suatom halogena ili okso, nitro, cijano, hidroksi, karbamoil, C1-C6 alkilsulfonil, C1-C6 alkiltio, C1-C6 alkilkarbonil ili C1-C6 alkilkarbonil-(C1-C6 )alkil skupina ili skupina formule -NR*R* gdje svaki R* nezavisno predstavlja atom vodika ili C1-C6 alkil, C1-C6 alkilkarbonil, fenil ili benzil skupinu, iliC1-C6 alkil, C2-C6 aleknil, C2-C6 alkinil ili C1-C6 alkoksi skupina, od kojih svaki može opcijski imati 1 do 8 nezavisno odabranih supstituenata od okso, halo, cijano, nitro, amino, hidroksi ili fenil, C3-C9 mono- ili bicikloalkil skupina koja opcijski ima od 1 do 3 nezavisno odabrana supstituenta C1-C6 alkil, okso, halo, cijano, nitro, amino, hidroksi ili fenil, iliskupina formula -A, -O-A, -C(O)-A, -(CH2)q-A, -NR**-A, -C(O)NR**-A, -NR**C(O)-A ili -OC(O)-A, gdje A predstavlja fenil skupinu ili C1-C8 heterocikličnu skupinu koja sadrži od 1 do 3 heteroatoma izabranih od dušika, kisika i sumpora, od kojih svaka A skupina može imati od 1 do 3 nezavisno odabranih supstituenata od halo, hidroksi, cijano, nitro i C1-C6 alkil; svaki R** nezavisno predstavlja atom vodika ili C1-C6 alkil skupinu iq je 0 ili cijeli broj od 1 do 6; uz uvjet da ukoliko Z predstavlja skupinu formule -CH=CH-R2, tada R1 predstavlja atom vodika, a okso i hidroksi su isključeni iz mogućih supstituenata, ili njegov enantiomer, diasteroizomer, N-oksid ili farmaceutski prihvatljiva sol. Patent sadrži još 14 patentnih zahtjeva.
Claims (15)
1. Spoj koji ima opću formulu I
[image]
gdje
Z predstavlja skupinu formule -C≡C-R2 ili -CH=CH-R2;
R1 predstavlja
• atom vodika ili halogena, ili
• hidroksi, cijano, C1-C6alkil, C1-C6 alkilkarbonil, C1-C6 alkoksi, C1-C6 alkoksikarbonil, C1-C6alkilkarboniloksi, C1-C6alkoksikarboniloksi, C1-C6alkiltio, di-(C1-C6alkil)-amino ili C3-C14 cikloalkil grupu;
R2 predstavlja
• opcijski supstituiranu mono- ili biciklo C1-C9 heterocikličnu skupinu koja sadrži od 1 do 3 heteroatoma izabrana od dušika, kisika i sumpora.
• opcijski supstituiranu mono-, bi- ili tricikličnu C6-C14 aril skupinu,
• opcijski supstituiranu C1-C6alkil skupinu,
• opcijski supstituiranu C2-C6 alkilenil skupinu ili
• opcijski supstituiranu C3-C6cikloalkil skupinu,
ili R2 predstavlja skupinu -C(O)-R2A, gdje je R2A definiran kao gore R2;
• R3 predstavlja
• atom vodika,
• opcijski supstituiranu C1-C6 alkil skupinu,
• opcijski supstituiranu mono-, bi- ili tricikličnu C1-C14 heterocikličnu skupinu koja sadrži 1 do 3 heteroatoma izabrana od dušika, kisika i sumpora,
• opcijski supstituiranu mono, bi ili tricikličnu C6-C14 aril skupinu,
• opcijski supstituiranu C3-C6cikloalkil skupinu ili
• opcijski supstituiranu C3-C6cikloalkenil skupinu,
Y predstavlja skupinu formule –C(O)-, -C(S)-, -NH-C(O)-, -N(C1-C6alkil)-C(O)-, -O-C(O)-,
-NH-C(S)-, -N(C1-C6alkil)-C(S)-, -O-C(S)- ili –SO2- ili je odsutan,
m je 0, 1 ili 2;
n je 0, 1 ili 2;
supstituenti za svaku opcijski supstituiranu skupinu su
• atom halogena ili okso, nitro, cijano, hidroksi, karbamoil, C1-C6alkilsulfonil, C1-C6alkiltio, C1-C6alkilkarbonil ili C1-C6alkilkarbonil-(C1-C6)alkil skupina ili skupina formule –NR*R* gdje svaki R* nezavisno predstavlja atom vodika ili C1-C6alkil, C1-C6alkilkarbonil, fenil ili benzil skupinu, ili
• C1-C6 alkil, C2-C6 aleknil, C2-C6 alkinil ili C1-C6 alkoksi skupina, od kojih svaki može opcijski imati 1 do 8 nezavisno odabranih supstituenata od okso, halo, cijano, nitro, amino, hidroksi ili fenil,
• C3-C9 mono- ili bicikloalkil skupina koja opcijski ima od 1 do 3 nezavisno odabrana supstituenta C1-C6 alkil, okso, halo, cijano, nitro, amino, hidroksi ili fenil, ili
• skupina formula –A, -O-A, -C(O)-A, -(CH2)q-A, -NR**-A, -C(O)NR**-A, -NR**C(O)-A ili –OC(O)-A,
gdje A predstavlja fenil skupinu ili C1-C8 heterocikličnu skupinu koja sadrži od 1 do 3 heteroatoma izabranih od dušika, kisika i sumpora, od kojih svaka A skupina može imati od 1 do 3 nezavisno odabranih supstituenata od halo, hidroksi, cijano, nitro i C1-C6alkil;
svaki R** nezavisno predstavlja atom vodika ili C1-C6alkil skupinu i
q je 0 ili cijeli broj od 1 do 6;
uz uvjet da ukoliko Z predstavlja skupinu formule –CH=CH-R2, tada R1 predstavlja atom vodika, a okso i hidroksi su isključeni iz mogućih supstituenata,
ili njegov enantiomer, diasteroizomer, N-oksid ili farmaceutski prihvatljiva sol.
2. Spoj prema zahtjevu 1 u kojem Z predstavlja skupinu formule -C≡C-R2, gdje je R2 kao što je definirano u zahtjevu 1.
3. Spoj prema zahtjevu 2, u kojem R1 predstavlja atom vodika ili fluora ili metil skupinu.
4. Spoj prema bilo kojem od prethodnih zahtjeva, u kojem je m 1 i n je 1.
5. Spoj prema bilo kojem od prethodnih zahtjeva, u kojem Y predstavlja skupinu formule –C(O)-, -NH-C(O)-, -N(C1-C6alkil)-C(O)-, -O-C(O)-, -NH-C(S)- ili –SO2- ili je odsutan.
6. Spoj prema bilo kojem od prethodnih zahtjeva, u kojem R2 predstavlja
• opcijski supstituiranu mono- ili biciklo C1-C9 heterocikličnu skupinu koja sadrži od 1 do 3 heteroatoma izabrana od dušika, kisika i sumpora,
• opcijski supstituiranu fenil skupinu,
• opcijski supstituiranu C1-C6 alkil skupinu,
• opcijski supstituiranu C2-C6 alkilenil skupinu ili
• opcijski supstituiranu C3-C6 cikloalkil skupinu,
ili R2 predstavlja skupinu –C(O)-R2A, gdje je R2A definiran kao R2 u ovom zahtjevu.
7. Spoj prema zahtjevu 6, u kojem R2 predstavlja opcijski supstituirani pirolidinil, tiazolil, piridil, kinolil, kinoksalinil ili fenil skupinu, a supstituenti za svaku opcijski supstituiranu skupinu su atom fluora, klora ili broma, okso, nitro, cijano, cijanometil, acetil, metil, metoksi, etoksi, izopropil, trifluorometil, trifluorometoksi, acetamino, 2,2-dimetilpropanoilamino, 3,3-dimetil-2-okso-1-azetidinil, 1-pirolidinilmetil, 1H-pirazol-1-il, 3-metil-1,2,4-oksadiazol-5-il ili morfolino skupina.
8. Spoj prema zahtjevu 7, u kojem R2 predstavlja piridil ili fenil skupinu supstituiranu sa atomom fluora i/ili metil skupinom, a drugi supstituenti su opcijski.
9. Spoj prema zahtjevu 7, u kojem R2 predstavlja 6-metil-2-piridil, 5-cijano-2-piridil, 3-fluorofenil, 2,5-difluorofenil skupinu ili 3,5-difluorofenil skupinu.
10. Spoj prema bilo kojem od prethodnih zahtjeva, u kojem R3 predstavlja
• C1-C6 alkil skupinu supstituiranu sa opcijski supstituiranom skupinom A,
• opcijski supstituiranu mono- ili biciklo- C1-C9 heterocikličnu skupinu koja sadrži 1 do 3 heteroatoma izabrana od dušika, kisika i sumpora,
• opcijski supstituiranu fenil skupinu,
• opcijski supstituiranu C3-C6 cikloalkil skupinu ili
• opcijski supstituiranu C3-C6 cikloalkenil skupinu.
11. Spoj prema zahtjevu 10, u kojem R3 predstavlja mono- ili bicikličnu C1-C9 heterocikličnu skupinu koja sadrži 1 do 3 heteroatoma izabrana od dušika, kisika i sumpora i barem 2 susjedna ugljikova atoma, od kojih je jedan vezan za atom dušika prikazanog prstena koji sadrži dušik (Y nije prisutan), drugi nosi cijano ili nitro supstituent, a ostali supstituenti su opcijski.
12. Spoj prema zahtjevu 10, u kojem R3 predstavlja opcijski supstituirani pirolidinil, pirazolil, imidazolil, 1,2,4-triazolil, izoksazolil, furil, tienil, piridil, piperidil, pirazinil, pirimidinil, morfolinil, imidazo[2,1-b]tiazolil, indolil, izoindolil, imidazo[1,2-a]piridil, 1,2,3-benzotriazolil, kinolil, izokinolil, kinoksalinil, pirido[2,3-b]pirazinil, 1,4-benzoksazinil ili fenil skupina, supstituenti za svaku opcijski supstituiranu skupinu su atom fluora, klora, broma ili joda ili metil, izopropil, metoksi, etoksi, propoksi, cijano, nitro, trifluorometil, trifluorometoksi, acetil, acetamino, fenil, benziloksi, fenilkarbamoil, 4-fluorofenil, 3-fluoro-4-metilfenil, 2-furil, 2-tienil, 4-piridil, piperidino, 2-pirimidinil, 2-pirimidiniloksi, 1,3-tiazol-2-il, 2-metil-1,3-tiazol-4-il, 2-okso-pirolidin-1-il, 5-metil-1,2,4-oksadiazol-3-il, 2,5-dimetil-1H-pirol-1-il skupina.
13. Spoj prema zahtjevu 10, u kojem R3 predstavlja 6-metil-3-nitro-2-piridil, 6-metil-3-cijano-2-piridil, 4-metoksi-3-cijano-2-piridil, 3-cijano-2-tienil ili 3-cijano-2-pirazil skupinu.
14. Bilo koji od slijedećih spojeva prema zahtjevu 1, ili njihov enantiomer, diasteroizomer, N-oksid ili farmaceutski prihvatljiva sol, naime:
• 1-(3-nitro-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(t-butoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-nitrofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metoksi-3-nitro-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-metil-2-nitrofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-metoksi-2-nitrofenil)-4-[3-(6-metil-2-piridil)-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-(3-fenil-prop-2-iniliden)-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-piridil)-prop-2-iniliden]-piperidin,
• 1-fenilkarbamoil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-morfolinokarbonil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-benzoil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-butilaminotiokarbonil-3-nitro-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-etilaminotiokarbonil-3-nitro-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(t-butilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitrofenilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitrobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-etoksikarbonil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-cikloheksilaminotiokarbonil-3-nitro-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-fenilaminotiokarbonil-3-nitro-2-piridil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(1-feniletil-karbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-butiril-4-[3-(6-metil-2-pirdil)-prop-2-iniliden]-piperidin,
• 1-butilkarbamoil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-etilkarbamoil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-benzil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-butil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(4-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-kinolil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-morfolino-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-fluoro-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-acetil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-izopropoksi-3-piridil)-prop-2-iniliden]piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-metoksi-2-piridil)-prop-2-iniliden]-piperidin,
• 1-fenil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-cijanofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-metoksi-2-nitrofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(t-butoksikarbonil)-4-[3-(5-cijano-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(t-butoksikarbonil)-4-[3-(6-cijano-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(5-cijano-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-cijano-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(t-butoksikarbonil)-4-[3-(2-metil-1,3-tiazol-4-il)-prop-2-iniliden]-piperidin,
• 4-[3-(2-metil-1,3-tiazol-4-il)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(2-metil-1,3-tiazol-4-il)-prop-2-iniliden]-piridin,
• 1-(4-cijano-3,5-difluorofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-cijano-2-metoksifenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-bromo-2-cijano-3-fluorofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-fluoro-2-nitrofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-cijano-2-nitrofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[2-(2,5-dimetil-1H-pirol-1-il)-5-pirimidinil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-kinoksalinil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-cijano-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-kidroksimetil-2-nitrofenil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-trifluorometil-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-triflurometil-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-trifluorometil-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(t-butoksikarbonil)-4-[1-fluoro-3-fenil-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[1-fluoro-3-fenil-prop-2-iniliden]-piperidin,
• 1-(2-metoksiietoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-cijanoetoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-benziloksikarbonil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-fluoro-4-nitro-fenoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-teinil-metoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-piridiloksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(1-metil-4-piperidiniloksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[2-(1H-indol-3-il)-etoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2,2,2-trifluoro-1-trifluorometil-etoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2,3,4-triflorofenoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(cikloheksiloksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(ciklobutilmetoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-bromo-2-piridiloksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-fenoksipropoksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4,6-dimetil-pirimidiniloksikarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(N-metil-N-fenilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(N,N-dietilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(N,N-dimetilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(N-metil-N-3-nitrofenilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(N-metil-N-butilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[N-metil-N-(t-butil)-karbamoil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(N-metil-N-etilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[N-metil-N-(1-feniletil)-karbamoil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(N-etil-N-izopropilkarbamoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(p-tolilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-nitrofenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-fenilsulfonil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[5-(2-okso-1-pirolidinil)-2-metil-fenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-metoksifenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-bromo-2,5-difluorofenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-benzilsulfonil-4-[3-(6-metil-2-piridinil)-prop-2-iniliden]-piperidin,
• 1-etinilsulfonil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-kloro-4-cijanofenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-fluorobenzilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-cikloheksilmetilsulfonil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-metil-3-nitrofenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2,2,2-trifluoroetilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-izopropilfenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-cijanofenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-kloro-2-metoksi-4-metilfenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(7,7-dimetil-2-okso-biciklo[2.2.1]hept-1-ilmetilsulfonil)-4-[3-(6-metil-2-piridinil)-prop-2-iniliden]piperidin,
• 1-[3-(4-metoksifenoksi)-propilsulfonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-bromofenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-bromo-2-fluorofenilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-kloro-imidazo[2,1-b]tiazol-5-ilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(1,2-dimetil-1H-imidazol-4-ilsulfonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[4-(1,2,3-tiadiazol-4-il)-fenilsulfonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[5-(t-butil)-2-metoksifenilsulfonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-nitrobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-pirazinilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-bromobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-fenil-4-oksibutiril-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3,4,5-trimetoksibenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-nitrobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-metil-2-nitrobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-heptanoil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-tienilkarbonil)-4-[3-(6-metil-2-piridinil)-prop-2-iniliden]-piperidin,
• 1-(4,4,4-trifluorobutiril)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[3-(2-piridmidiniloksi)-benzoil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-bromo-3-piridilacetil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-kinolilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[5-amino-5-okso-3-(4-klorofenil)-pentanoil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-ftalimidopropionil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-o-4,5-dimetoksibenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-metoksi-3-piridinilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[5-metil-1-(4-fluorofenil)-1H-1,2,4-triazol-3-ilkarbonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-bromofenoksiacetil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[3-(5-metil-1,2,4-oksadiazol-3-il)-benzoil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-ftalimidoacetil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-fluoro-1H-indol-3-ilacetil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-kloro-6-metoksi-4-piridilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(1-metil-1H-1,2,3-benzotriazol-5-ilkarbonil)-4-[3-(6-metil-2-piridinil)prop-2-iniliden]-piperidin,
• 1-(2-nitrofenoksiacetil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2,5-dimetil-3-furilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-kloro-2-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-jodobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3,5-difluorofenilacetil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2,6-dimetoksi-3-piridilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-kloro-6-metil-4-piridilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-metoksi-1H-indol-3-ilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3,3-dimetilbutiril)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-metoksibenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-metoksibenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-metoksibenzoil)-4-[3-(6-metil-2-piridinil)-prop-2-iniliden]-piperidin,
• 1-(2-metoksi-3-piridilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[1-(4-piridil)-4-piperidinilkarbonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[3(4H)-okso-2H-1,4-benzoksazin-6-ilkarbonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[3-(3-fluorofenoksi)-propionil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-piperidino-5-piridinilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[1-(3-fluoro-4-metilfenil)-2-okso-pirolidin-4-ilkarbonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-acetamido-2-metilbenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-klorobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-fenilbenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-furoil)-4-[3-(6-metil-2-piridinil)-prop-2-iniliden]-piperidin,
• 1-fenilacetil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]piperidin,
• 1-(4-fenilbutiril)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-fluorobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-metilbenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijanobenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-trifluorometoksibenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-trifluorometilbenzoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-bromo-2-furoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-nitro-2-furoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-fenil-2-furoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-kloro-2-tienilkarbonil)-4-[3-(6-metil-2-piridinil)-prop-2-iniliden]-piperidin,
• 1-(4-metil-2-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-metil-2-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2,5-dikloro-3-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-furoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-fenil-3-izolsazolilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[5-(2-tienil)-1H-pirazol-3-il-karbonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[5-(2-furil)-1H-pirazol-3-il-karbonil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-nitro-2-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-benziloksibenzoil-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-metil-2-furoil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-etoksi-2-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-acetil-2-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-fenil-2-teinilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[3-(2-metil-1,3-tiazol-4-il)-benzoil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-kloro-4-metoksi-3-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-metiltio-2-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-kloro-4-metil-2-tienilkarbonil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[3-(1,3-tiazol-2-il)-benzol]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-[3-(2-pirimidinil)-benzoil]-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-(4-okso-pent-2-iniliden)-piperidin,
• 1-(3-nitro-2-piridil)-4-[4-(4-fluorofenil)-4-okso-but-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-(5,5-dimetil-4-okso-heks-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[4-(2-tienil)-4-okso-but-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-(4-cikloheksil-4-okso-but-2-iniliden]-piperidin,
• 1-(3-nitro-2-pirdil)-4-(5-metil-4-okso-heks-5-en-2-iniliden)-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3,5-difluoro-4-metoksifenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(4-cijano-3-fluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(5-fluoro-2-metoksifenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(4-cijanofenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-{3-[4-(3,3-dimetil-2-okso-1-azetidinil)-fenil]-prop-2-iniliden}-piperidin,
• 1-(3-nitro-2-piridil)-4-{[4-(1-pirolidinilmetil)-fenil]-prop-2-iniliden}-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(2,3-dimetoksifenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-trifluorometilfenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-bromofenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-metilfenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-metoksifenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-kinoksalinil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-cijanometilfenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-nitrofenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-cijanofenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-klorofenil)-prop-2-iniliden]-piperidin,
• 1-(t-butoksikarbonil)-4-(hept-2-iniliden)-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-trifluorometil-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(2-fluoro-6-metil-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-bromo-2-kloro-4-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-bromo-2-fluoro-4-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-fluoro-4-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(5-fluoro-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-fluoro-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(6-izopropoksi-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(2-etoksi-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-nitro-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metoksi-3-nitro-2-piridil)-4-[3-(3,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(5-bromo-2-pirimidil)-4-[3-(6-metl-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-metil-5-nitro-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-cijano-3-metil-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-cijano-3-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-metil-3-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-izokinolil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-metil-5-okso-ciklopentil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-tienil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-nitro-2-furil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(5-fenilkarbamoil-2-furil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-metil-4-nitro-1H-5-imidazolil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(t-butoksikarbonil)-(3E)-3-[3-(6-metil-2-piridil)-prop-2-iniliden]-pirolidin,
• 1-(3-nitro-2-piridil)-4-(4-fenil-but-3-in-2-iliden)-piperidin,
• 1-(3-nitro-2-piridil)-4-[(2E)-3-fenil-prop-2-eniliden]-piperidin,
• 1-(3-nitro-imidazo[1,2a]piridin-2-il)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-trifluorometoksifenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(2-okso-1-pirolidinil)-prop-2-iniliden]-piperdin,
• 1-(5-trifluorometil-3-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-5-fenil-2-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(2-propoksi-3-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(pirido[2,3-b]pirazin-7-il)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-2-tienil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-etoksi-3-piridil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(2,6-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-nitro-2-piridil)-4-{3-[3-(1H-pirazol-1-ilmetil)-fenil]-prop-2-iniliden}-piperidin,
• 1-(3-nitro-2-piridil)-4-{3-[2-(2,2-dimetil-propionilamino)-3-piridil]-prop-2-iniliden}-piperidin,
• 1-(3-nitro-2-piridil)-4-{3-[3-(4-metil-piperazin-1-ilmetil)-fenil]-prop-2-iniliden}-piperidin,
• 1-(3-nitro-2-piridil)-4-[3-(3-acetilfenil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(4-fluoro-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil-4-[3-(3,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(3-fluorofenil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(6-fluoro-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(2-fluoro-4-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(5-fluoro-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(5-cijano-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(2,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(3,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(3-fluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(4-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(6-fluoro-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(5-cijano-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(2-fluoro-4-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(2,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(5-cijano-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(6-fluoro-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-[3-(5-fluoro-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoksi-2-piridil)-4-[3-(3-fluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoksi-2-piridil)-4-[3-(3,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoksi-2-piridil)-4-[3-(2,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoksi-2-piridil)-4-[3-(2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoksi-2-piridil)-4-[3-(6-fluoro-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoksi-2-piridil)-4-[3-(6-fluoro-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoki-2-piridil)-4-[3-(2-fluoro-4-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoksi-2-piridil)-4-[3-(5-fluoro-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoki-2-piridil)-4-[3-(5-cijano-3-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-4-metoksi-2-piridil)-4-[3-(5-cijano-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-6-metil-2-piridil)-4-(4-fenil-but-3-in-2-iliden)-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(6-bromo-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(3-etoksifenil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(3-acetilfenil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(3-acetamidofenil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-[3-(3-acetonilfenil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-3-(3Z)-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-3-(3E)-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-(4-fenil-but-3-in-2-iliden)-piperidin,
• 1-(1-metil-4-nitro-1H-imidazol-5-il)-4-(4-fenil-but-3-in-2-iliden)-piperidin,
• 1-(1-metil-4-nitro-1H-imidazol-5-il)-4-[3-(3,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(1-metil-4-nitro-1H-imidazol-5-il)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(4-nitro-1H-imidazol-5-il)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin,
• 1-(3-cijano-2-tienil)-4-[3-(2,5-difluorofenil)-prop-2-iniliden]-piperidin,
• 1-(6-metil-3-nitro-2-piridil)-4-{3-[3-(3-metil-1,2,4-oksadiazol-5-il)-fenil]-prop-2-iniliden}-piperidin ili
• 1-(2-cijano-3-pirazinil)-4-[3-(6-metil-2-piridil)-prop-2-iniliden]-piperidin.
15. Farmaceutski sastav koji sadrži spoj prema bilo kojem od prethodnih zahtjeva, ili njegov enantiomer, diasteroizomer, N-oksid ili farmaceutski prihvatljivu sol u smjesi sa farmaceutski prihvatljivim razblaživačem ili nosačem.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95367707P | 2007-08-02 | 2007-08-02 | |
US4517508P | 2008-04-15 | 2008-04-15 | |
PCT/EP2008/006351 WO2009015897A1 (en) | 2007-08-02 | 2008-08-01 | Novel heterocyclic compounds as mglu5 antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20120225T1 true HRP20120225T1 (hr) | 2012-04-30 |
Family
ID=39885225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20120225T HRP20120225T1 (hr) | 2007-08-02 | 2012-03-12 | Novi heterociklični spojevi kao mglu5 antagonisti |
Country Status (23)
Country | Link |
---|---|
US (1) | US8518916B2 (hr) |
EP (1) | EP2178858B1 (hr) |
JP (1) | JP5412430B2 (hr) |
KR (1) | KR20100052507A (hr) |
CN (1) | CN101821256A (hr) |
AT (1) | ATE539075T1 (hr) |
AU (1) | AU2008282032B2 (hr) |
BR (1) | BRPI0814182A2 (hr) |
CA (1) | CA2694359A1 (hr) |
CY (1) | CY1112500T1 (hr) |
DK (1) | DK2178858T3 (hr) |
EA (1) | EA018328B1 (hr) |
ES (1) | ES2380165T3 (hr) |
HK (1) | HK1141788A1 (hr) |
HR (1) | HRP20120225T1 (hr) |
IL (1) | IL203659A (hr) |
NZ (1) | NZ582934A (hr) |
PL (1) | PL2178858T3 (hr) |
PT (1) | PT2178858E (hr) |
RS (1) | RS52167B (hr) |
SI (1) | SI2178858T1 (hr) |
WO (1) | WO2009015897A1 (hr) |
ZA (1) | ZA201001467B (hr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8937148B2 (en) | 2012-09-07 | 2015-01-20 | Empire Technology Development LLP | Regioregular copolymers and methods for making same |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010089119A1 (en) * | 2009-02-04 | 2010-08-12 | Recordati Ireland Limited | Heterocyclic derivatives as m-glu5 antagonists |
US20120028931A1 (en) * | 2009-09-14 | 2012-02-02 | Recordati Ireland Limited | Heterocyclic m-glu5 antagonists |
AR084516A1 (es) * | 2010-12-22 | 2013-05-22 | Merz Pharma Gmbh & Co Kgaa | Moduladores de receptores de glutamato metabotropicos |
AR084515A1 (es) * | 2010-12-22 | 2013-05-22 | Merz Pharma Gmbh & Co Kgaa | Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras |
WO2013098095A1 (en) * | 2011-12-27 | 2013-07-04 | Dsm Ip Assets B.V. | Catalytic synthesis of vitamin a intermediate |
CN102827056B (zh) * | 2012-09-03 | 2014-07-23 | 华东理工大学 | N-芳基取代吡咯烷酮衍生物及其用途 |
JP6416125B2 (ja) | 2013-02-04 | 2018-10-31 | プレクストン・セラピューティクス・ソシエテ・アノニム | mGluR3の正のアロステリックモジュレーター |
MX2019015015A (es) * | 2017-06-29 | 2020-08-06 | Recordati Ind Chimica E Farmaceutica S P A | Derivados de heterociclilmetilideno y su uso como moduladores de los receptores de mglur5. |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE24826E (en) * | 1956-08-30 | 1960-05-17 | N-alkylpiperidyl alkynylamines | |
JPS5995249A (ja) * | 1982-11-24 | 1984-06-01 | Ono Pharmaceut Co Ltd | ロイコトリエンb4類似化合物、その製造方法及びそれらを有効成分として含有する治療剤 |
CA2080536A1 (en) * | 1991-10-17 | 1993-04-18 | John S. Ward | Nicotinic activity of a series of arecolones and isoarecolones |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
CA2366858A1 (en) * | 1999-04-01 | 2000-10-12 | Margaret Yuhua Chu-Moyer | Sorbitol dehydrogenase inhibitors |
US6265434B1 (en) * | 1999-04-06 | 2001-07-24 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
TW593241B (en) | 1999-04-20 | 2004-06-21 | Hoffmann La Roche | Carbamic acid derivatives |
ITMI991452A1 (it) * | 1999-07-01 | 2001-01-01 | Mediolanum Farmaceutici Srl | Antagonisti selettivi per i recettori m2 con struttura 5h-dibenzo b,fazepinica |
US6387909B1 (en) * | 1999-07-30 | 2002-05-14 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyranecarboxamide derivatives |
US6306861B1 (en) * | 1999-07-30 | 2001-10-23 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyrancecarboxamide derivatives |
US6548522B1 (en) | 1999-10-12 | 2003-04-15 | Hoffmann-La Roche Inc. | Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives |
US6403594B1 (en) * | 1999-10-18 | 2002-06-11 | Recordati, S.A. Chemical And Pharmaceutical Company | Benzopyran derivatives |
US6365591B1 (en) * | 1999-10-18 | 2002-04-02 | Recordati, S.A., Chemical And Pharmacueticals Company | Isoxazolecarboxamide derivatives |
SV2002000205A (es) | 1999-11-01 | 2002-06-07 | Lilly Co Eli | Compuestos farmaceuticos ref. x-01095 |
PT1294358E (pt) | 2000-06-28 | 2004-12-31 | Smithkline Beecham Plc | Processo de moagem por via humida |
US6369222B1 (en) * | 2000-07-18 | 2002-04-09 | Hoffmann-La Roche Inc. | mGluR antagonists and a method for their synthesis |
WO2003093236A1 (en) * | 2002-05-02 | 2003-11-13 | Euro-Celtique, S.A. | 1-(pyrid-2-yl)-piperazine compounds as metabotropic glutamate receptor inhibitor |
US7348337B2 (en) * | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
RU2333210C2 (ru) * | 2002-08-16 | 2008-09-10 | Янссен Фармацевтика Н.В. | Соединения пиперидинила, селективно связывающие интегрины |
EP1558599A4 (en) | 2002-10-30 | 2007-06-27 | Merck & Co Inc | HETEROARYLPIPERIDINE MODULATORS DERCHEMOKIN RECEPTORACTIVITY |
ATE490244T1 (de) * | 2003-01-27 | 2010-12-15 | Merck Sharp & Dohme | Substituierte pyrazole, zusammensetzungen,die solche verbindungen enthalten, und anwendungsverfahren |
ITMI20030151A1 (it) * | 2003-01-30 | 2004-07-31 | Recordati Ind Chimica E Farma Ceutica S P A | Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore. |
US7338954B2 (en) * | 2003-09-17 | 2008-03-04 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
FR2866884B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique |
US20050239751A1 (en) | 2004-03-26 | 2005-10-27 | Rigel Pharmaceuticals, Inc. | Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
AU2005231440B9 (en) * | 2004-04-02 | 2012-02-23 | Dogwood Pharmaceuticals, Inc. | Selective antagonists of A2A adenosine receptors |
GB0503646D0 (en) * | 2005-02-22 | 2005-03-30 | Novartis Ag | Organic compounds |
EP1863804A1 (en) * | 2005-04-01 | 2007-12-12 | Methylgene, Inc. | Inhibitors of histone deacetylase |
GB0514296D0 (en) * | 2005-07-12 | 2005-08-17 | Novartis Ag | Organic compounds |
JP5301999B2 (ja) * | 2005-10-31 | 2013-09-25 | メルク・シャープ・アンド・ドーム・コーポレーション | Cetp阻害薬 |
AU2007234843B2 (en) * | 2006-04-07 | 2013-07-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
US7985754B2 (en) | 2006-07-17 | 2011-07-26 | Trovis Pharmaceuticals, Llc | Selective antagonists of A2A adenosine receptors |
-
2008
- 2008-08-01 SI SI200830533T patent/SI2178858T1/sl unknown
- 2008-08-01 CN CN200880101389A patent/CN101821256A/zh active Pending
- 2008-08-01 JP JP2010518567A patent/JP5412430B2/ja not_active Expired - Fee Related
- 2008-08-01 PL PL08785292T patent/PL2178858T3/pl unknown
- 2008-08-01 AT AT08785292T patent/ATE539075T1/de active
- 2008-08-01 PT PT08785292T patent/PT2178858E/pt unknown
- 2008-08-01 AU AU2008282032A patent/AU2008282032B2/en not_active Expired - Fee Related
- 2008-08-01 WO PCT/EP2008/006351 patent/WO2009015897A1/en active Application Filing
- 2008-08-01 DK DK08785292.7T patent/DK2178858T3/da active
- 2008-08-01 KR KR1020107004641A patent/KR20100052507A/ko not_active Application Discontinuation
- 2008-08-01 ES ES08785292T patent/ES2380165T3/es active Active
- 2008-08-01 NZ NZ582934A patent/NZ582934A/en not_active IP Right Cessation
- 2008-08-01 BR BRPI0814182-7A2A patent/BRPI0814182A2/pt not_active IP Right Cessation
- 2008-08-01 EP EP08785292A patent/EP2178858B1/en active Active
- 2008-08-01 RS RS20120110A patent/RS52167B/en unknown
- 2008-08-01 EA EA201000283A patent/EA018328B1/ru not_active IP Right Cessation
- 2008-08-01 CA CA2694359A patent/CA2694359A1/en not_active Abandoned
- 2008-08-04 US US12/185,639 patent/US8518916B2/en not_active Expired - Fee Related
-
2010
- 2010-02-02 IL IL203659A patent/IL203659A/en not_active IP Right Cessation
- 2010-03-01 ZA ZA2010/01467A patent/ZA201001467B/en unknown
- 2010-07-28 HK HK10107247.4A patent/HK1141788A1/xx not_active IP Right Cessation
-
2012
- 2012-03-12 HR HR20120225T patent/HRP20120225T1/hr unknown
- 2012-03-21 CY CY20121100296T patent/CY1112500T1/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8937148B2 (en) | 2012-09-07 | 2015-01-20 | Empire Technology Development LLP | Regioregular copolymers and methods for making same |
US9181287B2 (en) | 2012-09-07 | 2015-11-10 | Empire Technology Development Llc | Regioregular copolymers and methods for making same |
Also Published As
Publication number | Publication date |
---|---|
EA201000283A1 (ru) | 2010-06-30 |
ZA201001467B (en) | 2010-11-24 |
EA018328B1 (ru) | 2013-07-30 |
AU2008282032B2 (en) | 2014-08-07 |
RS52167B (en) | 2012-08-31 |
US8518916B2 (en) | 2013-08-27 |
EP2178858B1 (en) | 2011-12-28 |
SI2178858T1 (sl) | 2012-03-30 |
US20090042841A1 (en) | 2009-02-12 |
ES2380165T3 (es) | 2012-05-09 |
CA2694359A1 (en) | 2009-02-05 |
KR20100052507A (ko) | 2010-05-19 |
NZ582934A (en) | 2011-10-28 |
BRPI0814182A2 (pt) | 2015-01-27 |
IL203659A (en) | 2013-06-27 |
WO2009015897A1 (en) | 2009-02-05 |
JP5412430B2 (ja) | 2014-02-12 |
HK1141788A1 (en) | 2010-11-19 |
JP2010535165A (ja) | 2010-11-18 |
CY1112500T1 (el) | 2015-12-09 |
CN101821256A (zh) | 2010-09-01 |
PL2178858T3 (pl) | 2012-07-31 |
ATE539075T1 (de) | 2012-01-15 |
PT2178858E (pt) | 2012-02-24 |
AU2008282032A1 (en) | 2009-02-05 |
EP2178858A1 (en) | 2010-04-28 |
DK2178858T3 (da) | 2012-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20120225T1 (hr) | Novi heterociklični spojevi kao mglu5 antagonisti | |
JP2010535165A5 (hr) | ||
JP2006500348A5 (hr) | ||
AU2007304475B2 (en) | Substituted sulfonamide derivatives | |
CA2476343C (en) | 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors | |
US6562811B1 (en) | Pyridine derivatives | |
ES2629414T3 (es) | Derivados de tiazol | |
JP5814917B2 (ja) | 特に睡眠障害及び薬物中毒の治療に適したスピロアミノ化合物 | |
US7622471B2 (en) | Pyrazole derivatives having a pyridazine and pyridine functionality | |
CN112638373A (zh) | 细胞周期蛋白依赖性激酶抑制剂 | |
EP2473502A1 (en) | Heteroaryl compounds as kinase inhibitors | |
EP1165545A1 (en) | Novel compounds | |
JP5432249B2 (ja) | 新規なヘテロアリールカルボキシアミド誘導体 | |
JP2019523266A5 (hr) | ||
US20040082551A1 (en) | Novel pyrazoles and their use as p38 kinase inhibitors | |
JP2006512412A5 (ja) | 神経系の疾患の治療用のベンズアゼピン誘導体 | |
JP2008513405A5 (hr) | ||
EP2308854A1 (en) | 2,3,6-trisubstituted-4-pyrimidone derivatives | |
RU2005134006A (ru) | Производные 4-(4-{гетероциклилалкокси}фенил0-1-(гетероциклилкарбонил)пиперидина и родственные соединения как антагонисты гистамина н3 для лечения неврологических заболеваний, таких как болезнь альцгеймера | |
AU2010291199A1 (en) | Pyrazinylpyridines useful for the treatment of proliferative diseases | |
EP1667990A2 (en) | New compounds | |
CA2522536A1 (en) | Five-membered heterocyclic derivative | |
CA2756005A1 (en) | Substituted piperidines as par-1 antagonists | |
RU2010136707A (ru) | Новые гетероциклы | |
WO2019170904A1 (en) | Piperidines or piperidones substituted with urea and phenyl |